Cipla Ltd - Company Profile
Powered by 
All the data and insights you need on Cipla Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date Cipla Ltd Strategy Report
- Understand Cipla Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Cipla Ltd (Cipla) manufactures and distributes branded medicines, generics and active pharmaceutical ingredients (APIs). It offers products in therapeutic areas such as cardiovascular and pediatric diseases, dermatological and cosmetological conditions, HIV/AIDS, diabetes, hepatitis, infectious diseases and critical care, neurological, ophthalmic, cancer, malaria, respiratory and urological conditions, osteoporosis and women's health. The company also operates in consumer healthcare and biosimilar businesses. Cipla manufactures metered-dose inhaler devices, spacers and related devices; and conducts R&D to develop new medicines and drug delivery systems. The company has operations in India, US, Canada, South Africa and major regulated and emerging markets among others. Cipla is headquartered in Mumbai, Maharashtra, India.
Headquarters
India
Address
Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai, Maharashtra, 400013
Website
www.cipla.com
Telephone
91 22 24826000
No of Employees
26,615
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
CIPLA (NSE)
Revenue (2022)
$2.9B
4.5%
(2022 vs 2021)
EPS
XYZ
Net Income (2022)
XYZ
11.3%
(2022 vs 2021)
Market Cap*
$13.3B
Net Profit Margin (2022)
XYZ
6.5%
(2022 vs 2021)
* As of and is in US$
Cipla Ltd premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Drugs and Therapies: | Cipla |
| Cardiovascular | Cippoint |
| Dermatology and Cosmetology | Synchrobreathe |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2024 | Contracts/Agreements | In April, Cipla Health entered into an agreement to acquire the cosmetics and personal care distribution and marketing business from Ivia Beaute Pvt Ltd. |
| 2024 | Contracts/Agreements | In March, the company entered into a partnership with Sanofi India Limited and Sanofi Healthcare India Private Limited to broaden the reach of its CNS portfolio in India. |
| 2024 | Contracts/Agreements | In February, the company entered into a research partnership with CSIR-Central Drug Research Institute to produce a novel ophthalmic formulation for fungal keratitis. |
Competitor Comparison
| Key Parameters | Cipla Ltd | Sun Pharmaceutical Industries Ltd | Aurobindo Pharma Ltd | Dr. Reddy's Laboratories Ltd | Zydus Lifesciences Ltd |
|---|---|---|---|---|---|
| Headquarters | India | India | India | India | India |
| City | Mumbai | Mumbai | Hyderabad | Hyderabad | Ahmedabad |
| State/Province | Maharashtra | Maharashtra | Telangana | Telangana | Gujarat |
| No. of Employees | 26,615 | 41,000 | 15,690 | 24,832 | 23,026 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Umang Vohra | Chief Executive Officer - Global; Managing Director; Director | Executive Board | 2016 | - |
| Raju Mistry | President; Chief People Officer | Senior Management | 2019 | - |
| Pradeep Bhadauria | Chief Scientific Officer - Global; President | Senior Management | 2020 | - |
| Shivam S. Puri | Chief Executive Officer - Cipla Healthcare Ltd | Senior Management | 2019 | - |
| Rajeev Kumar Sinha | Chief Manufacturing Officer | Senior Management | 2024 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward